Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving transferase
Patent
1997-07-16
2000-05-09
Leary, Louise N.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving transferase
435183, 435968, 435 4, 435 18, 435 23, 435 24, 435 21, C12Q 148, C12Q 100, C12Q 137
Patent
active
060602627
ABSTRACT:
The present invention relates to drug screening assays which provide a systematic and practical approach for the identification of candidate agents able to inhibit ubiquitin-mediated degradation of I.kappa.B and other I.kappa.B-related polypeptides.
REFERENCES:
patent: 5597898 (1997-01-01), Ghosh
patent: 5776717 (1998-07-01), Cao
Yaron et al; The EMBO Jour; vol. 16(21); pp. 6486-6494; 1997 Month not available. Please print.
Adcock, I. et al., "Oxidative stress induces NF.kappa.B DNA binding and inducible NOS mRNA in human epithelilal cells", Biochem. Biophys. Res. Comm., 199: 1518 (1994).
Brennan, P and O'Neill, L., "Effects of oxidants and antioxidants on nuclear factor .kappa.B activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals", Biochim. Biophys. Acta, 1260(2): 167-175 (1995).
Dawson, S. et al., "The 26S-proteasome: regulation and substrate recognition", Mol. Bio. Rep., 24(1-2):39-44 (1997).
DiDonato, J. et al., "Mapping of the inducible I.kappa.B phosphorylation sties that signal its ubiquitination and degradation", Mol. Cell. Biol., 16(4): 1295-1304 (1997).
Frantz, B. and O'Neill, E., "The effect of sodium salicylate and aspirin on NF-.kappa.B", Science, 270(5244):2017-2019 (1995).
Grilli, M. et al., "Neuprotection by aspirin and sodium salicylate through blockade of NF-.kappa.B activation", Science, 274(5291):1383-1385 (1996).
Henkel, T. et al., "Rapid proteolysis of I.kappa.B-alpha is necessary for activation of transcription factor NF-.kappa.B", Nature, 365(6442): 182-185 (1993).
Huibregtse, J. et al., "A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase", Proc. Nat. Acad. Sci., 92:2563-2567 (1995).
Krappmann, D et al., "Different mechanisms control signal-induced degradation and basal turnover of the NF-.kappa.B inhibitor I.kappa.B alpha in vivo", EMBO J., 15(23):6716-6726 (1996).
Lee, F et al., "Activation of the I.kappa.B.alpha. kinase complex by MEKK1, a kinase of the JNK pathway", Cell, 88(2): 213-222 (1997).
Kopp, E. and Ghosh, S., "Inhibition of NF-.kappa.B by sodium salicylate and aspirin", Science, 265(5174): 956-959 (1994).
Meyer, M. et al., "Regulation of the transcription factors NF-.kappa.B and AP-1 redox changes", Chem. Biol. Interact, 91(2-3):91-100 (1994).
Meyer, M. et al., "H.sub.2 O.sub.2 and antioxidants have opposite effects on activation of NF-.kappa.B and AP-1 in intact cells: AP-1 asa secondary antioxidant-responsive factor", EMBO J., 12(5):2005-2015 (1993).
Milligan, S. et al., "Inhibition of I.kappa.B-.alpha. and I.kappa.B-.beta. proteolysis by calpain inhibitor I blocks nitric oxide synthesis", Arch. Biochem Biophys., 335(2): 388-395 (1996).
Miyamoto, S. et al., "Tumor necrosis factor a-induced phosphorylation of I.kappa.B.alpha. is a signal for its degradation but not dissociation from NF-.kappa.B", Proc. Nat. Acad. Sci., 91: 12740 (1994).
Muller, J. et al., "Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates", Methods, 11(3): 301-312 (1997).
Pierce, J. et al., "Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration", J. Immunol., 156(10):3961-3969 (1996).
Rodriguez, M. et al., "Identification of lysine residues required for signal-induced ubiquitination and degradation of I.kappa.B-.alpha. in vivo", Oncogene, 12(11):2425-2425-2435 (1996).
Rolfe, M et al., "The ubiquitin-mediated proteolytic pathway as a therapeutic area", J. Mol. Med., 75(1): 5-17 (1997).
Schmidt, K. et al., "The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B", Chem. Biol., 2(1): 13-22 (1995).
Schreck, R. et al., "Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1", EMBO J., 10(8):2247-2258 (1991).
Singh, S. et al., "Site-specific tyrosine phosphorylation of I.kappa.B.alpha. negatively regulates its inducible phosphorylation and degradation", J. Biol. Chem., 271(49): 31049-31054 (1996).
Suzuki, Y. et al., "Signal transduction for nuclear factor-kappa B activation. Proposed location of antioxidant-inhibitable step", J. Immunol., 153(11): 5008-5015 (1994).
Traenckner, E. et al., "a proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is bound to NF-kappa B", EMBO J., 13(22): 5433-5441 (1994).
Weil, R. et al., "Regulation of I.kappa.B.beta. degradation. Similarities to and differences from I.kappa.B.alpha.", J. Biol. Chem., 272(15): 9942-9949 (1997).
Chemical Abstracts, 122(21), Abstract No. 259803 (1995).
International Search Report, completed on Nov. 18, 1998.
GenBank Accession # 285983, Definition # KIAA0010.
GenBank Accession # 517115, Definition # KIAA0032.
GenBank Accession # 460711, Definition # KIAA0045.
Beer-Romero Peggy
Glass Susan J.
Rolfe Mark
Strack Peter J.
Campbell Paula
Leary Louise N.
Mitotix, Inc.
Vincent Matthew P.
LandOfFree
Regulation of I Kappa B (I.kappa.B) degradation and methods and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of I Kappa B (I.kappa.B) degradation and methods and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of I Kappa B (I.kappa.B) degradation and methods and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1063780